LC
EDSA icon

Lindbrook Capital’s Edesa Biotech EDSA Stock Holding History

Lindbrook Capital’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2
Closed – – 1419
2018
Q4 		$0 Buy
+2
New +$94 ﹤0.01% 1374

Other funds holding EDSA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Lindbrook Capital's EDSA Position: Q1 2019 in Review

Lindbrook Capital sold out of Edesa Biotech (EDSA) in Q1 2019, closing a stake of 2 shares.

Lindbrook Capital first reported a position in EDSA in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 11 funds tracked by Wall St. Rank hold EDSA as of Q1 2019.

  • Lindbrook Capital reported no remaining Edesa Biotech position as of Q1 2019 after selling out during the quarter.
  • Lindbrook Capital sold 2 Edesa Biotech shares in Q1 2019.
  • Lindbrook Capital first reported a position in Edesa Biotech in Q4 2018 and held it in 1 quarter.
  • Lindbrook Capital's Edesa Biotech position peaked at $0 in Q4 2018.
  • 11 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2019.

Based on Lindbrook Capital's 13F filing for Q1 2019, filed 23 Apr 2019.